Evidence map›Paper›PMID 30459451›Full record

ArticleScientific reports2018

Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide.

Weijun Xuan, Ya He, Liyi Huang, Ying-Ying Huang, Brijesh Bhayana, Liyan Xi, Jeffrey A Gelfand, Michael R Hamblin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Tetracyclines: light-activated antibiotics?Future medicinal chemistry · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Weijun XuanDepartment of Otorhinolaryngology, Head and Neck Surgery, First Clinical Medical College and Hospital, Guangxi University of Chinese Medicine, Nanning, China.
Ya HeWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Liyi HuangWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Ying-Ying HuangWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Brijesh BhayanaWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Liyan XiDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Jeffrey A GelfandDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA. JGELFAND@mgh.harvard.edu.
Michael R HamblinWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA. Hamblin@helix.mgh.harvard.edu.ORCID http://orcid.org/0000-0001-6431-4605
Harvard University · USMassachusetts General Hospital · USSun Yat-sen University · CN

Funding

Photodynamic Therapy of Localized InfectionsR01AI050875 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2003 to 2017
$4.8M
Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract InfectionsR21AI121700 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HAMBLIN, MICHAEL R · 2016 to 2017
$462k
National Natural Science Foundation of China (National Science Foundation of China) 81260239National Natural Science Foundation of China (National Science Foundation of China) 81260552National Natural Science Foundation of China (National Science Foundation of China) 81373700National Natural Science Foundation of China (National Science Foundation of China) 81472002National Natural Science Foundation of China (National Science Foundation of China) 81774374Natural Science Foundation of Guangxi Province (Guangxi Natural Science Foundation) 2016GXNSFAA380312NIAID NIH HHS R01 AI050875NIAID NIH HHS R21 AI121700U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI050875U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI121700
6 · The paper itself

Abstract

Tetracyclines (including demeclocycline, DMCT, or doxycycline, DOTC) represent a class of dual-action antibacterial compounds, which can act as antibiotics in the dark, and also as photosensitizers under illumination with blue or UVA light. It is known that tetracyclines are taken up inside bacterial cells where they bind to ribosomes. In the present study, we investigated the photochemical mechanism: Type 1 (hydroxyl radicals); Type 2 (singlet oxygen); or Type 3 (oxygen independent). Moreover, we asked whether addition of potassium iodide (KI) could potentiate the aPDI activity of tetracyclines. High concentrations of KI (200-400 mM) strongly potentiated (up to 5 logs of extra killing) light-mediated killing of Gram-negative Escherichia coli or Gram-positive MRSA (although the latter was somewhat less susceptible). KI potentiation was still apparent after a washing step showing that the iodide could penetrate the E. coli cells where the tetracycline had bound. When cells were added to the tetracycline + KI mixture after light, killing was observed in the case of E. coli showing formation of free molecular iodine. Addition of azide quenched the formation of iodine but not hydrogen peroxide. DMCT but not DOTC iodinated tyrosine. Both E. coli and MRSA could be killed by tetracyclines plus light in the absence of oxygen and this killing was not quenched by azide. A mouse model of a superficial wound infection caused by bioluminescent E. coli could be treated by topical application of DMCT and blue light and bacterial regrowth did not occur owing to the continued anti biotic activity of the tetracycline.

Indexed as

AnimalsAnti-Bacterial AgentsDrug SynergismEscherichia coliEscherichia coli InfectionsHydrogen PeroxideMethicillin-Resistant Staphylococcus aureusMice, Inbred BALB CPhotochemotherapyPhotosensitizing AgentsPotassium IodideSinglet OxygenTetracyclinesTyrosineWound InfectionAnti-Bacterial AgentsHydrogen PeroxidePhotosensitizing AgentsPotassium IodideSinglet OxygenTetracyclinesTyrosine

Identifiers

PMID30459451
PMCPMC6244358
OpenAlexW2901174606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.